Lymphocytic interstitial pneumonitis in autoimmune thyroid disease

Area of Science:

• Immunology
• Pulmonology
• Endocrinology

Background:

• Autoimmune thyroid disease (AITD) encompasses conditions like Hashimoto's thyroiditis and Graves' disease, involving immune system attacks on the thyroid gland.
• Lymphocytic interstitial pneumonitis (LIP) is a rare lung disease characterized by the infiltration of lymphocytes into the lung interstitium, often idiopathic or associated with other conditions.

Observation:

• Four patients presented with concurrent autoimmune thyroid disease and lymphocytic interstitial pneumonitis.
• These patients were not on medications known to induce LIP.
• Clinical observations included a positive response to steroid treatment and symptom relapse upon steroid withdrawal.

Findings:

• The observed response to steroids and subsequent relapse suggest an underlying immunologic basis for LIP in these patients.
• This indicates that LIP may be a pulmonary manifestation of the immune dysregulation present in autoimmune thyroid disease.

Implications:

• The findings suggest a potential link between autoimmune thyroid disease and lymphocytic interstitial pneumonitis, expanding the known spectrum of AITD manifestations.
• This highlights the importance of considering autoimmune thyroid disease in patients diagnosed with idiopathic LIP and vice versa.
• Further research into the immunopathogenesis of this association could lead to novel therapeutic strategies for both conditions.